Differentially expressed circulating miRNAs in postmenopausal osteoporosis: a meta-analysis

Elif Pala1, Tuba Denkçeken2

  • 1Department of Medical Biology, Faculty of Medicine, SANKO University, Gaziantep, Turkey epala@sanko.edu.tr.

Bioscience Reports
|April 27, 2019
PubMed

Insights

Circulating microRNAs (miRNAs) show promise for diagnosing postmenopausal osteoporosis (PMO). This study identified hsa-miR-133a-3p as a key biomarker, potentially useful for non-invasive diagnosis and treatment of PMO.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biomarker Discovery

Background:

  • MicroRNAs (miRNAs) are critical in postmenopausal osteoporosis (PMO) pathogenesis.
  • Increasing research focuses on miRNAs as diagnostic markers for PMO.
  • Identifying specific miRNAs can aid in early detection and management of PMO.

Purpose of the Study:

  • To identify key microRNAs (miRNAs) in postmenopausal osteoporosis (PMO) as potential biomarkers.
  • To evaluate the diagnostic value of specific miRNAs in PMO.
  • To explore the therapeutic potential of identified miRNAs in PMO.

Main Methods:

  • Systematic literature search of PubMed, Web of Science, Embase, and Cochrane Library.
  • Meta-analysis using robust rank aggregation (RRA) on 16 miRNA expression studies (327 PMO patients, 328 controls).
  • Bioinformatics analysis for target gene prediction and pathway enrichment (Kyoto Encyclopedia of Genes and Genomes).

Main Results:

  • A significant meta-signature of up-regulated hsa-miR-133a-3p (P = 1.38e-03) was identified in PMO.
  • Bioinformatics analysis linked hsa-miR-133a-3p to pathways including adrenergic signaling, adherens junction, PI3K-Akt, and AMPK signaling.
  • Six hub genes (CDC42, RHOA, EGFR, VAMP2, PIK3R2, FN1) were identified, enriched in signaling and cancer pathways.

Conclusions:

  • Circulating hsa-miR-133a-3p may serve as a potential non-invasive biomarker for PMO.
  • hsa-miR-133a-3p presents a potential therapeutic target for postmenopausal osteoporosis.
  • Further research is warranted to validate hsa-miR-133a-3p as a clinical biomarker for PMO.

Related Concept Videos

Directing Effect of Substituents: meta-Directing Groups01:09

Directing Effect of Substituents: meta-Directing Groups

Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
5.9K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.7K
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
6.9K
Overview of Pulmonary Circulation01:19

Overview of Pulmonary Circulation

The pulmonary circulation is a vital system in our body that acts as a bridge between the respiratory and cardiovascular systems. It serves as a transport network for deoxygenated blood from the heart to the lungs and then returns oxygen-rich blood back to the heart.
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...
2.9K
Overview of Systemic and Pulmonary Circulation01:15

Overview of Systemic and Pulmonary Circulation

The systemic and pulmonary circuits are crucial components of the circulatory system, working together to transport blood between the heart, lungs, and the rest of the body. The process begins with pulmonary circulation, where deoxygenated blood is pumped from the right ventricle to the lungs via the pulmonary trunk and arteries. Upon reaching the lungs, the blood becomes oxygenated and returns to the heart, specifically to the left atrium, via the pulmonary veins.
The oxygenated blood is sent...
10.5K
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H01:13

meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H

All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.6K